Reports Q1 revenue $10B, consensus $9.88B. “Our first-quarter results reflect a strong start to the year, and we are raising our full-year sales and EPS guidance,” said Robert Ford, chairman and CEO, Abbott. “This was the fifth consecutive quarter that we delivered double-digit organic sales growth in our underlying base business, which included particularly strong results in Medical Devices and Established Pharmaceuticals.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABT: